Effect of chemotherapy on pulmonary epithelial permeability in lung cancer
dc.contributor.author | Sayit E. | |
dc.contributor.author | Aktoǧu S. | |
dc.contributor.author | Ertay T. | |
dc.contributor.author | Çapa G. | |
dc.contributor.author | Erkmen G. | |
dc.contributor.author | Özbilek E. | |
dc.contributor.author | Büyükşirin M. | |
dc.contributor.author | Durak H. | |
dc.date.accessioned | 2024-07-22T08:25:42Z | |
dc.date.available | 2024-07-22T08:25:42Z | |
dc.date.issued | 2000 | |
dc.description.abstract | The aim of this study is to investigate the effect of one-course chemotherapy on the pulmonary epithelial permeability. Eighteen patients (18 male; mean age: 59 ± 10 years) with lung cancer (11 non-small cell, 7 small cell) inhaled 40 mCi (1,480 MBq) 99mTc-diethylenetriaminepentaacetic acid (DTPA). Thirty images of 1-min duration were acquired from posterior projection. The first 7 min of the decay-corrected time activity curves were used to calculate lung clearance half-time. Clearance half-times of 99mTc-DTPA from the peripheral regions of the lungs were 42 ± 19 min before and 56 ± 34 min after chemotherapy (p = 0.009); from the central regions, clearance half-times were 112 ± 94 min before and 160 ± 125 min after chemotherapy (p = 0.005). This decrease in clearance rate might be related to decreasing mucociliary clearance rate due to the toxic effect of the chemotherapy regimen on cilia movement and/or mucus structure. 99mTc-DTPA radioaerosol study can be used to monitor the toxic effects of chemotherapy on the pulmonary epithelium and possibly on mucociliary function. (C) 2000 Elsevier Science Inc. | |
dc.identifier.DOI-ID | 10.1016/S0969-8051(00)00133-5 | |
dc.identifier.issn | 09698051 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20555 | |
dc.language.iso | English | |
dc.subject | Antineoplastic Combined Chemotherapy Protocols | |
dc.subject | Blood Gas Analysis | |
dc.subject | Carcinoma, Non-Small-Cell Lung | |
dc.subject | Carcinoma, Small Cell | |
dc.subject | Cell Membrane Permeability | |
dc.subject | Cisplatin | |
dc.subject | Doxorubicin | |
dc.subject | Etoposide | |
dc.subject | Forced Expiratory Volume | |
dc.subject | Humans | |
dc.subject | Ifosfamide | |
dc.subject | Lung | |
dc.subject | Lung Neoplasms | |
dc.subject | Male | |
dc.subject | Metabolic Clearance Rate | |
dc.subject | Middle Aged | |
dc.subject | Mitomycin | |
dc.subject | Mucociliary Clearance | |
dc.subject | Respiratory Mucosa | |
dc.subject | Technetium Tc 99m Pentetate | |
dc.subject | Vital Capacity | |
dc.subject | antineoplastic agent | |
dc.subject | cisplatin | |
dc.subject | doxorubicin | |
dc.subject | etoposide | |
dc.subject | ifosfamide | |
dc.subject | mitomycin | |
dc.subject | pentetate technetium tc 99m | |
dc.subject | adult | |
dc.subject | aged | |
dc.subject | article | |
dc.subject | bronchus mucus | |
dc.subject | cancer chemotherapy | |
dc.subject | clinical article | |
dc.subject | drug cytotoxicity | |
dc.subject | half life time | |
dc.subject | human | |
dc.subject | lung alveolus epithelium | |
dc.subject | lung cancer | |
dc.subject | lung clearance | |
dc.subject | lung scintiscanning | |
dc.subject | male | |
dc.subject | membrane permeability | |
dc.subject | mucociliary clearance | |
dc.subject | mucociliary transport | |
dc.title | Effect of chemotherapy on pulmonary epithelial permeability in lung cancer | |
dc.type | Article |